Canacord Genuity short sale at odds with forecast.At 12:25:58 EDT today, Canacord Genuity was at both ends of a short sale totalling 2,474,600 ACB shares at $6.15. This number is significant given it represents almost 25% of todays total traded volume.
What I find troubling about this is that Cannacord Genuity's own analyst, Matt Bottomly, was interviewed on the Midas Letter July 27th touting ACB would hit $11 per share! Anyone have an explanation?